+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904628
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atrial Fibrillation Surgery Market grew from USD 2.67 billion in 2023 to USD 2.90 billion in 2024. It is expected to continue growing at a CAGR of 9.00%, reaching USD 4.88 billion by 2030.

Major types of atrial fibrillation surgeries include catheter ablation, surgical ablation, and left atrial appendage closure (LAAC). Over the years, there has been a significant prevalence of chronic diseases such as diabetes and hypertension, which are key risk factors for developing AFib; as a result, demand for effective AFib treatment options has surged. Innovations in minimally invasive techniques, such as catheter ablation, have significantly improved patient outcomes while reducing recovery time. However, product recalls associated with AFib surgical products, limited reimbursements for surgeries, and limited availability of surgeons to conduct the procedure also impact the market. Market players are creating affordable devices or techniques that enable greater accessibility to life-saving treatments for patients across different socioeconomic backgrounds. Continued research in areas such as artificial intelligence, robotics, and bioelectronic medicine is expected to lead to the development of innovative AFib surgery solutions that further improve patient outcomes and minimize complications.

Regional Insights

North America's atrial fibrillation surgery market observes an advancing landscape driven by the well-established healthcare infrastructure and favorable reimbursement policies to conduct surgical procedures. There have been several innovative medication products and devices approved by the U.S. Food & Drug Administration (FDA) and Health Canada in the region, portraying an improved development scenario. In Asia-Pacific, countries such as India, Japan, and China have seen a rapid increase in AFib surgeries due to a large patient pool suffering from cardiovascular diseases uptaking surgical procedures. Substantial growth in medical tourism in Asia has accelerated the number of surgeries conducted in the region, expanding the need for advanced surgical tools and devices. The production aspect of AF surgery is growing in Asia, especially in China and Japan, due to the presence of major medical device manufacturers focusing on developing cost-effective solutions to cater to the ever-growing demand for affordable healthcare services. Europe is another significant market for AFib, with many European-based companies focusing on developing innovative cardiac devices used during AF surgeries. Key players have made substantial investments in research and development activities aimed at advancing surgical technologies for treating atrial fibrillation patients effectively.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Atrial Fibrillation Surgery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rise in prevalence of atrial fibrillation in geriatric population
  • Development in preference of catheter ablation for cardiac arrhythmia treatment
  • Growing number of AF programs to enhance public awareness

Market Restraints

  • Regulatory issues associated with the devices

Market Opportunities

  • Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
  • Technological advances for catheter ablation of atrial fibrillation

Market Challenges

  • Lack of skilled professionals and awareness among the people about the surgery

Market Segmentation Analysis

  • Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
  • Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
  • End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Atrial Fibrillation Surgery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Atrial Fibrillation Surgery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

GE HealthCare has launched CardioVisio for Atrial Fibrillation (AFib), a digital tool specifically designed to assist clinicians in visualizing longitudinal data for disease progression. With the introduction of CardioVisio, clinicians are able to save valuable time and make more informed clinical decisions, improved explainability and traceability and also it enables healthcare providers to offer personalized and evidence-based care to their patients.

Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

Biosense Webster, a global player in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, has obtained approval from the U.S. Food and Drug Administration (FDA) for multiple products in its cardiac ablation portfolio. These products are able to be utilized in conjunction with a zero fluoroscopy workflow.

Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias

Medtronic PLC has obtained the CE Mark for its Affera Mapping and Ablation System consisting of the Sphere-9 Catheter and the Affera Prism-1 Mapping Software. The approval is expected to enhance commercialization to provide mapping and ablation for atrial arrhythmias, specifically Atrial Fibrillation (AFib), a condition that affects large populations worldwide.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Atrial Fibrillation Surgery Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Cardiac Cryoablation Catheters
  • Cardiac Mapping System

Indication

  • Atrial Fibrillation (AFib)
  • Atrial Flutter
  • Supraventricular Tachycardia (SVT)

End-User

  • Cardiology
  • Multi Specialities

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
5.1.1.3. Growing number of AF programs to enhance public awareness
5.1.2. Restraints
5.1.2.1. Regulatory issues associated with the devices
5.1.3. Opportunities
5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
5.2. Market Segmentation Analysis
5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Atrial Fibrillation Surgery Market, by Product
6.1. Introduction
6.2. Cardiac Cryoablation Catheters
6.3. Cardiac Mapping System
7. Atrial Fibrillation Surgery Market, by Indication
7.1. Introduction
7.2. Atrial Fibrillation (AFib)
7.3. Atrial Flutter
7.4. Supraventricular Tachycardia (SVT)
8. Atrial Fibrillation Surgery Market, by End-User
8.1. Introduction
8.2. Cardiology
8.3. Multi Specialities
9. Americas Atrial Fibrillation Surgery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Atrial Fibrillation Surgery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. ATRIAL FIBRILLATION SURGERY MARKET RESEARCH PROCESS
FIGURE 2. ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ATRIAL FIBRILLATION SURGERY MARKET DYNAMICS
FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 48. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 49. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 50. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 56. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 102. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 138. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 158. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 159. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 170. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 176. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 182. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 212. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 218. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 224. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 248. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 266. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Acesion Pharma ApS
  • Acutus Medical, Inc
  • Affera, Inc.
  • AFreeze GmbH
  • Atrian Medical Ltd.
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Cardiofocus, Inc.
  • CathRx Ltd
  • Cook Group Incorporated
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Healium Medical
  • Japan Lifeline Co.
  • Johnson & Johnson Services, Inc.
  • Kardium Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • OMEICOS Therapeutics GmbH
  • Osypka AG
  • SentiAR, Inc
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
  • Thryv Therapeutics Inc.
  • Toray Medical Co., Ltd.
  • Vanguard AG
  • Volta Medical

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.88 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal

Related Topics

Related Reports

Global Atrial Fibrillation Surgery Market 2024-2028 - Product Image

Global Atrial Fibrillation Surgery Market 2024-2028

  • Report
  • 142 Pages
  • Global
From
Global Tissue Ablation Market by Type (Minimally Invasive Surgery, Open Surgery), Technology (Cryoablation, Electrical Ablation, Hydromechanical Ablation), Indication - Forecast 2024-2030 - Product Image

Global Tissue Ablation Market by Type (Minimally Invasive Surgery, Open Surgery), Technology (Cryoablation, Electrical Ablation, Hydromechanical Ablation), Indication - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Forecast 2024-2030 - Product Image

Global Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Atrial Fibrillation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Atrial Fibrillation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Electrophysiology Devices - Global Strategic Business Report - Product Image

Electrophysiology Devices - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From

About the Atrial Fibrillation Surgery Market

Atrial Fibrillation Surgery is a type of surgical procedure used to treat a heart condition known as atrial fibrillation. This condition is characterized by an irregular heartbeat, which can lead to a variety of symptoms such as chest pain, shortness of breath, and fatigue. The goal of the surgery is to restore the heart's normal rhythm and reduce the risk of stroke. The most common type of atrial fibrillation surgery is the Maze procedure, which involves creating a series of small incisions in the heart to create a maze-like pattern. Other types of atrial fibrillation surgery include catheter ablation, cryoablation, and radiofrequency ablation. The Atrial Fibrillation Surgery market is composed of a variety of companies that provide products and services related to the diagnosis and treatment of atrial fibrillation. These companies include medical device manufacturers, healthcare providers, and research organizations. Examples of companies in the Atrial Fibrillation Surgery market include Medtronic, St. Jude Medical, Boston Scientific, and Biosense Webster. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.